Related Experiment Video

Updated: Jun 5, 2026

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)
08:10

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)

Published on: September 14, 2011

[Present activity of BCG and LTBI treatment for infants in Japan]

Hitoshi Hoshino1

  • 1Research Institute of Tuberculosis, Japan Anit-Tuberculosis Association (JATA), Tokyo, Japan. hhoshino@jata.or.jp

Kekkaku : [Tuberculosis]
|December 24, 2010
PubMed

Insights

BCG vaccination and latent tuberculosis infection (LTBI) treatment strategies were analyzed for infants in Japan. Improved BCG coverage and contact surveys for LTBI treatment are recommended for infant tuberculosis prevention.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Context:

  • Tuberculosis (TB) prevention in infants is critical.
  • Analysis focuses on 2008 infant notification data in Japan.
  • Examines the roles of BCG vaccination and latent tuberculosis infection (LTBI) treatment.

Purpose:

  • To evaluate the effectiveness of BCG vaccination and LTBI treatment strategies for infant TB prevention.
  • To identify optimal timing and coverage for interventions.
  • To inform public health policies for reducing infant TB incidence.

Summary:

  • Early infant TB prevention relied on LTBI treatment, with limited notification.
  • Later implementation of BCG vaccination showed high coverage (61.5-97.7%) and lower TB incidence in vaccinated infants.
  • BCG vaccination demonstrated a protective effect, with lower breakdown rates compared to unvaccinated infants.

Impact:

  • Findings suggest reinforcing contact surveys for LTBI identification and treatment.
  • Improving BCG vaccination coverage is crucial.
  • Targeted attention to unvaccinated infants over 6 months is recommended for effective infant TB prevention.

More Related Videos

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...